Industry: Healthcare | Publish Date: 06-Dec-2024 | No of Pages: 122 | No. of Tables: 77 | No. of Figures: 50 | Format: PDF | Report Code : HC1273
The Taiwan Dialysis Market size was valued at USD 203.6 million in 2023 and is predicted to reach USD 317.5 million by 2030, with a CAGR of 6.1% from 2024 to 2030.
The dialysis market encompasses the global industry focused on providing treatments and services for patients with kidney failure or severe kidney dysfunction. It includes a wide range of components such as medical devices including dialysis machines and dialyzers, which are essential for performing hemodialysis and peritoneal dialysis.
The market also covers pharmaceuticals that help manage complications associated with kidney failure, including anemia treatments and phosphate binders. Dialysis services comprise both in-center treatments conducted in specialized clinics and home dialysis options, which allow patients to manage their care in the comfort of their own homes. Technological innovations, such as digital health solutions for patient management and portable dialysis devices, are increasingly transforming patient care.
The increasing prevalence of chronic kidney disease (CKD) in Taiwan, driven by the rising rates of diabetes, hypertension, and lifestyle changes drives the demand for dialysis treatments. As reported by BenQ Dialysis, in 2023, approximately 2.5 million individuals in Taiwan are affected by some form of kidney disease, with over 90,000 people currently undergoing dialysis treatment. As more individuals require therapy, healthcare facilities are expanding their services to meet demand, that in turn boosts the renal dialysis market growth.
The growing geriatric population in Taiwan is a crucial factor propelling the expansion of the dialysis market, as elderly individuals are particularly vulnerable to CKD. As the risk of CKD rises with age, the demand for dialysis treatments is expected to grow in Taiwan, boosting the growth of the market.
The latest report from the Global Taiwan Institute indicates that the proportion of those aged 65 and above in Taiwan is projected to rise to 19% between 2019 and 2050. This significant demographic shift underscores the increasing healthcare challenges posed by an aging population, necessitating enhanced medical services, including dialysis.
The rising number of diabetes patients in Taiwan is significantly fueling the country's dialysis market, as individuals with diabetes face a higher risk of kidney-related complications, necessitating regular dialysis treatment for health maintenance.
According to the International Diabetes Federation (IDF), the number of diabetes patients in Taiwan was approximately 24.5 million in 2021, and it is projected to reach 30.3 million by 2045, reflecting a 23.7% increase over 24 years. This growing prevalence of diabetes is driving the demand for advanced dialysis solutions and comprehensive renal care, contributing to the expansion of the dialysis market in Taiwan.
The shortage of skilled healthcare professionals, including nephrologists and dialysis nurses, presents a significant challenge to Taiwan dialysis market growth. This lack of trained personnel directly impacts the availability and quality of dialysis services, as a limited number of professionals struggle to meet the increasing demand for treatment. Consequently, the absence of experienced staff results in delays in treatment, leading to a decline in overall patient care quality, hindering the market's growth.
Advancements in kidney dialysis technology, particularly the development of portable dialysis devices, are expected to create significant growth opportunities for the market in the coming years. These innovations enable treatments in various settings, such as homes and workplaces, thereby enhancing patient enterprise mobility and independence while reducing time spent in clinics.
Healthcare providers are able to effectively monitor patients remotely, utilizing intuitive interfaces and remote monitoring capabilities that minimize the need for in-person visits. As a result, the evolution of portable kidney dialysis technology presents substantial opportunities for improving treatment outcomes and fostering patient independence, creating significant opportunities in the Taiwan dialysis market demand.
Hemodialysis dominates the Taiwan dialysis market share, as it is considered the standard treatment for end-stage renal disease (ESRD), supported by extensive clinical evidence affirming its efficacy and safety.
Moreover, the robust network of dialysis centers in Taiwan ensures easy accessibility to hemodialysis to patients with CKDs, hemodialysis is known for its rapid effectiveness in removing waste products from the blood, improving patient outcomes and managing complications.
The homecare segment is anticipated to show the Taiwan dialysis market trends, with a compound annual growth rate (CAGR) of 8.3% from 2024 to 2030. This growth due to the increasing number of patients adopting home-based dialysis treatment for convenience and improved quality of life.
The rising geriatric population, particularly those with chronic kidney disease, further drives this trend, as older patients often prefer homecare options. Additionally, advancements in dialysis technology along with the growing awareness & acceptance of home dialysis options among healthcare IT providers and patients is expected to contribute significantly to the market expansion in the coming years.
Several key market players operating in the Taiwan dialysis industry include Fresenius Medical Care, Baxter International, Inc., B. Braun, Nikkiso Co. Ltd., Medtronic plc, HI-CLEARANCE INC, Becton, Dickinson and Company, BenQ Dialysis Technology Corp, and Bioteque Corporation, Excelsior Medical Co., Ltd. among others.
Hemodialysis
Conventional Hemodialysis
Hemofiltration
On-line Hemodiafiltration
Off-line Hemodiafiltration
Peritoneal Dialysis
Conventional Dialysis
Short Daily Dialysis
Nocturnal Dialysis
Equipment
Dialysis Machines
Dialyzers
Bloodlines
Other Equipment
Consumables
Dialysis Fluids
Catheters
Dialysis Access Devices
Other Consumables
Services
Dialysis Treatment Services
Maintenance and Support Services
Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers
Fresenius Medical Care
Baxter International, Inc.
B. Braun
Nikkiso Co. Ltd.
Medtronic plc
HI-CLEARANCE INC
Becton, Dickinson and Company
BenQ Dialysis Technology Corp
Bioteque Corporation
Excelsior Medical Co., Ltd.
Parameters |
Details |
Market Size in 2023 |
USD 203.6 Million |
Revenue Forecast in 2030 |
USD 317.5 Million |
Growth Rate |
CAGR of 6.1% from 2024 to 2030 |
Analysis Period |
2023–2030 |
Base Year Considered |
2023 |
Forecast Period |
2024–2030 |
Market Size Estimation |
Million (USD) |
Growth Factors |
|
Companies Profiled |
10 |
Market Share |
Available for 10 companies |
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |